About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Not Yet RecruitingPhase 3

A Randomized Study of a Short Duration Therapy for Candidemia

NCT06859671•Assistance Publique - Hôpitaux de Paris

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

CANDIDEMIA

Interventions

Standard of Care (SOC)

Shortened duration of antifungal therapy

Key Dates

Start Date

July 1, 2025

Primary Completion Date

September 1, 2027

Completion Date

September 1, 2027

Last Updated

March 5, 2025

Related Studies

RECRUITINGPhase 3

A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.

NCT05421858

CandidemiaCandidiasis, Invasive

COMPLETEDPhase 3

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT04368559

CandidemiaMycoses+8 more

TERMINATEDPhase 3

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

NCT05178862

Candidiasis, InvasiveCandidemia

COMPLETEDPhase 3

Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)

NCT03363841

Candidiasis, InvasiveCandidemia

COMPLETEDPhase 3

Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis

NCT03667690

CandidemiaMycoses+2 more

Echinocandins Versus Azoles for Candidemia Treatment

NCT03799172

View all related studies

Contacts

Blandine Denis, MD

CONTACT

+33142494585 blandine.denis@aphp.fr

Jérôme Lambert, MD PhD

CONTACT

+33 1 42 49 97 42 jerome.lambert@u-paris.fr

Sponsors

Lead Sponsor

Assistance Publique - Hôpitaux de Paris

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 5, 2025Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions